A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
Janssen Research & Development, LLC
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
AbbVie
Florida International University
AbbVie
Takeda
University Health Network, Toronto
Amgen
Inmune Bio, Inc.
University of Kansas Medical Center
AbbVie
Sumitomo Pharma America, Inc.
AbbVie
Celgene
University of Louisville
Sunesis Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
Case Comprehensive Cancer Center